相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of single-dose dexamethasone implantation for patients with persistent diabetic macular edema: a systematic review and meta-analysis
Qiongzhen Yuan et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)
Initial treatment of macular oedema due to central retinal vein occlusion-which anti-VEGF agent to choose?
Elad Moisseiev et al.
EYE (2020)
Ozurdex for refractory macular edema secondary to diabetes, vein occlusion, uveitis and pseudophakia
Salina Teja et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2019)
Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study
Iias Georgalas et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2019)
Intravitreal dexamethasone implant Ozurdex® in naive and refractory patients with different subtypes of diabetic macular edema
Veronica Castro-Navarro et al.
BMC OPHTHALMOLOGY (2019)
A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
Ye He et al.
BMC OPHTHALMOLOGY (2018)
Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion
Sandra Rezar-Dreindl et al.
ACTA OPHTHALMOLOGICA (2017)
Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion
Kleanthis Manousaridis et al.
INTERNATIONAL OPHTHALMOLOGY (2017)
Retinal Vein Occlusion - Which Treatment When?
A. Bajor et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2017)
Comparison of Intravitreal Ranibizumab, Aflibercept, and Dexamethasone Implant after Bevacizumab Failure in Macular Edema Secondary to Retinal Vascular Occlusions
Joel Hanhart et al.
OPHTHALMOLOGICA (2017)
Retinal Vein Occlusions: Therapeutic Switch in Macular Oedema Treatment with a 12-Month Follow-Up
Christophe Chiquet et al.
OPHTHALMIC RESEARCH (2016)
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion 52-Week Results of the VIBRANT Study
W. Lloyd Clark et al.
OPHTHALMOLOGY (2016)
Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
Josh Wallsh et al.
CLINICAL OPHTHALMOLOGY (2016)
Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus
Alan R. Berger et al.
OPHTHALMOLOGICA (2015)
Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab The RETAIN Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2014)
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
Julie Glanville et al.
BMC OPHTHALMOLOGY (2014)
Baseline Characteristics and Response to Treatment of Participants With Hemiretinal Compared With Branch Retinal or Central Retinal Vein Occlusion in the Standard Care vs COrticosteroid for REtinal Vein Occlusion (SCORE) Study
Ingrid U. Scott et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
Improved Vision-Related Function after Ranibizumab for Macular Edema after Retinal Vein Occlusion Results from the BRAVO and CRUISE Trials
Rohit Varma et al.
OPHTHALMOLOGY (2012)
The burden of disease of retinal vein occlusion: review of the literature
M. Laouri et al.
EYE (2011)
Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion
Julia A. Haller et al.
OPHTHALMOLOGY (2011)
Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2011)
Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant
Joan-En Chang-Lin et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Vitreous levels of interleukine-8 and monocyte chemoattractant protein-1 in macular oedema with branch retinal vein occlusion
A. Fonollosa et al.
EYE (2010)
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
David M. Brown et al.
OPHTHALMOLOGY (2010)
Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion
Julia A. Haller et al.
OPHTHALMOLOGY (2010)
Vitreous Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Macular Edema with Central Retinal Vein Occlusion
Hidetaka Noma et al.
OPHTHALMOLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Age-related macular degeneration and low-vision rehabilitation: a systematic review
Phil Hooper et al.
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2008)
Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas
Xinynan Zhang et al.
DIABETES (2008)
Ranibizumab for macular edema due to retinal vein occlusions: Implication of VEGF as a critical stimulator
Peter A. Campochiaro et al.
MOLECULAR THERAPY (2008)
Rebound macular edema following bevacizumab (avastin) therapy for retinal venous occlusive disease
Yoko Matsumoto et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)
Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity
BS Kang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2001)
分享论文
